Expedited Partner Therapy: STI Treatment for Sexual Partners

For example:

1. one person tests positive for chlamydia;
2. a clinician treats that person;
3. medication or a prescription is also provided for a recent sexual partner;
4. the partner takes the medicine without first having a full examination.

EPT can make partner treatment faster and reduce the chance that the original patient becomes infected again.

• expedited, meaning made faster or completed more quickly;
• partner, referring to a sexual partner;
• therapy, meaning medical treatment.

Examples include:

• The clinic offered expedited partner therapy after her chlamydia diagnosis.
• EPT can reduce reinfection when sexual partners are treated promptly.
• Expedited partner therapy is regulated differently in different places.

Common expressions include:

• offer EPT;
• provide partner medication;
• EPT prescription;
• partner treatment;
• STI partner management;
• reinfection prevention.

An untreated partner may still carry the infection and can:

• transmit it to others;
• reinfect the treated person;
• develop complications.

Some partners do not seek testing or treatment because of:

• cost;
• lack of healthcare access;
• transportation problems;
• embarrassment;
• difficulty arranging appointments.

EPT attempts to overcome some of these barriers.

Many people with chlamydia have no symptoms.

Without treatment, infection may persist and be passed between partners.

EPT can help ensure that recent partners receive treatment even when they would otherwise delay or avoid clinical care.

Treating partners also reduces the likelihood of reinfection after the original patient completes treatment.

Management can be more complicated because:

• recommended treatment may change;
• antibiotic resistance is an important concern;
• some preferred treatments may normally be given by injection;
• other infections may be present at the same time.

Clinicians should follow current local guidance when considering EPT for gonorrhea.

Partner notification means informing recent sexual partners that they may have been exposed to an STI.

EPT goes further by providing treatment or a prescription.

A partner receiving EPT should usually also receive information about:

• the diagnosed infection;
• how to take the medicine;
• possible side effects;
• when to seek medical care;
• STI testing.

• examination;
• testing;
• diagnosis;
• treatment.

With EPT, treatment may be provided before an examination.

This can improve speed and access.

However, EPT may miss opportunities to diagnose:

• another STI;
• pregnancy;
• medication allergies;
• complications;
• symptoms requiring examination.

For this reason, EPT complements rather than completely replaces sexual-health care.

This is because treatment for one infection does not necessarily treat others.

Testing may be relevant for:

• HIV;
• syphilis;
• gonorrhea;
• chlamydia;
• other infections based on exposure.

A person who has symptoms should generally seek clinical evaluation rather than relying only on medication passed through a partner.

A person should seek care if they have symptoms such as:

• significant pelvic or lower abdominal pain;
• fever;
• testicular pain or swelling;
• severe genital pain;
• genital sores;
• unusual bleeding;
• pregnancy with concerning symptoms.

These may indicate conditions that require examination or different treatment.

It can happen when:

• one partner is treated;
• another infected partner remains untreated;
• sexual contact resumes;
• the infection is passed back.

EPT helps reduce this cycle by making partner treatment easier and faster.

Preventing reinfection is especially important because repeated chlamydial infection may increase the risk of reproductive complications.

The purpose is to prevent transmission while treatment is working.

Sexual contact should generally not resume until:

• treatment requirements have been completed;
• the recommended waiting period has passed;
• relevant partners have also been treated.

Exact recommendations depend on the infection and medication used.

PID may affect the:

• uterus;
• fallopian tubes;
• ovaries.

Possible complications include:

• chronic pelvic pain;
• ectopic pregnancy;
• infertility.

By helping partners receive treatment promptly, EPT can contribute indirectly to preventing repeated exposure and some STI-related complications.

A pregnant partner who may have been exposed to an STI should ideally receive appropriate medical assessment.

Information accompanying EPT should explain when pregnancy, allergies, symptoms, or other medical conditions require consultation with a healthcare professional.

Medication that is appropriate for one person may not automatically be appropriate for every partner.

Relevant concerns may include:

• medication allergy;
• current medicines;
• pregnancy;
• kidney or liver conditions;
• previous adverse reactions.

Written treatment information can help partners recognize when they should seek medical advice before taking the medication.

Using inappropriate antibiotics can:

• fail to cure infection;
• contribute to resistant bacteria;
• delay correct treatment.

EPT should therefore follow established treatment guidelines rather than using whatever antibiotic happens to be available.

This concern is particularly relevant to gonorrhea because resistance patterns can change over time.

It is not ordinarily used as a substitute for full medical evaluation of infections such as:

• HIV;
• syphilis.

These conditions require specific testing, diagnosis, treatment, and follow-up.

A person receiving EPT for chlamydia or gonorrhea may still need testing for HIV or syphilis depending on their sexual exposure.

Rules may determine:

• which infections qualify;
• whether the partner’s name is required;
• how prescriptions are written;
• which healthcare professionals may provide EPT.

Because laws and clinical recommendations can change, healthcare professionals should follow current local requirements.

Partner communication should respect privacy as much as possible.

The diagnosed person may need to tell a partner that:

• exposure occurred;
• treatment has been provided;
• testing may still be recommended.

Healthcare systems may also offer confidential partner-notification services in some locations.

The partner should receive enough information to make an informed decision.

Useful information may include:

• what infection they were exposed to;
• why medication is being offered;
• how to take it;
• possible side effects;
• situations requiring medical care.

Clear communication can make partner treatment safer and more effective.

• faster partner treatment;
• fewer barriers to care;
• reduced reinfection;
• reduced STI transmission;
• increased treatment of partners who might otherwise remain untreated.

EPT can be especially useful when partners are unlikely to obtain prompt healthcare on their own.

The partner may miss:

• comprehensive STI testing;
• physical examination;
• HIV prevention counseling;
• vaccination;
• diagnosis of another condition.

EPT therefore works best as a targeted public-health tool rather than a complete replacement for sexual-health services.

EPT is used for every STI.
No. It is mainly used for selected infections such as chlamydia and, in some settings, gonorrhea.

A partner receiving EPT never needs STI testing.
No. Testing for the diagnosed infection and other STIs may still be important.

EPT replaces all medical care.
No. Symptoms, pregnancy, allergies, or possible complications may require direct clinical assessment.

EPT encourages unnecessary antibiotic use.
When used according to clinical guidelines, it targets partners with meaningful exposure to a diagnosed infection.

Only the diagnosed person needs treatment.
No. Untreated partners can contribute to reinfection and continued transmission.

1. Expedited partner therapy can help treat sexual partners after a chlamydia diagnosis.
2. The clinician provided medication for the patient’s recent partner.
3. Can expedited partner therapy reduce reinfection?
4. A partner who receives EPT may still need STI testing.
5. EPT is not used as a substitute for medical care in every infection.
6. Treating exposed partners can reduce continued transmission.
7. Local laws influence how expedited partner therapy is provided.
8. Understanding expedited partner therapy helps readers connect STI treatment, partner care, reinfection prevention, and sexual-health communication.

EPT can reduce reinfection and continued transmission by making treatment easier to access. At the same time, respectful partner communication, STI testing, informed medication use, and confidentiality remain important.

Understanding expedited partner therapy supports practical, nonjudgmental sexual-health care by treating STI exposure as a shared medical issue rather than a reason for blame or stigma.